Maravai LifeSciences Holdings, Inc. reaffirmed financial guidance for the full year 2024. Revenue expectations for 2024 remain in the range of $265.0 million to $285.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.78 USD | -2.44% | -2.88% | +64.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.58% | 1.47B | |
-26.90% | 9.87B | |
-16.78% | 2.75B | |
-17.50% | 2.13B | |
-24.25% | 1.65B | |
+31.92% | 811M | |
-5.02% | 733M | |
-29.59% | 510M | |
+0.20% | 300M | |
-28.40% | 166M |
- Stock Market
- Equities
- MRVI Stock
- News Maravai LifeSciences Holdings, Inc.
- Maravai LifeSciences Holdings, Inc. Reaffirms Financial Guidance for the Full Year 2024